Literature DB >> 21561112

Persistence of the three-state description of mixed valency at the localized-to-delocalized transition.

Starla D Glover1, Clifford P Kubiak.   

Abstract

Application of a semiclassical three-state model of mixed valency to complexes of the type [Ru(3)(μ(3)-O)(OAc)(6)(CO)(py)-(μ(2)-BL)-Ru(3)(μ(3)-O)(OAc)(6)(CO)(py)](-1), where BL = 1,4-pyrazine or 4,4'-bipyridine and py = 4-dimethylaminopyridine, pyridine, or 4-cyanopyridine is described. The appearance of two intervalence charge transfer (IVCT) bands in the near-infrared (NIR) region of the electronic spectra of these complexes is explained well by the three-state model. An important feature of the three-state model is that the IVCT band evolves into two bands: one that is metal-to-bridging-ligand-charge-transfer (MBCT) in character and another that is metal-to-metal-charge-transfer (MMCT) in character. The three-state model also fully captures the observed spectroscopic behavior in which the MBCT transition increases in energy and the MMCT band decreases in energy with increasing electronic communication in a series of mixed valence ions. The appearance of both the MBCT and MMCT bands is found to persist as coalescence of infrared (IR) vibrational spectra suggest a ground state delocalized on the picosecond time scale. The solvent and temperature dependence of the MBCT and MMCT electronic transitions defines the mixed valence complexes reported here as lying on the borderline of delocalization.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21561112     DOI: 10.1021/ja2022784

Source DB:  PubMed          Journal:  J Am Chem Soc        ISSN: 0002-7863            Impact factor:   15.419


  1 in total

1.  Delocalization tunable by ligand substitution in [L2Al] n- complexes highlights a mechanism for strong electronic coupling.

Authors:  Amela Arnold; Tobias J Sherbow; Amanda M Bohanon; Richard I Sayler; R David Britt; Allison M Smith; James C Fettinger; Louise A Berben
Journal:  Chem Sci       Date:  2020-11-04       Impact factor: 9.825

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.